These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31434577)

  • 1. Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis.
    Arenja N; Andre F; Riffel JH; Siepen FAD; Hegenbart U; Schönland S; Kristen AV; Katus HA; Buss SJ
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):53. PubMed ID: 31434577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis.
    Ochs MM; Fritz T; Arenja N; Riffel J; Andre F; Mereles D; Siepen FAD; Hegenbart U; Schönland S; Katus HA; Friedrich MGW; Buss SJ
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):87. PubMed ID: 29121956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis.
    Hu M; Song Y; Yang C; Wang J; Zhu W; Kan A; Yang P; Dai J; Yu H; Gong L
    Sci Rep; 2024 Jul; 14(1):16832. PubMed ID: 39039146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
    Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
    BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
    Riffel JH; Keller MG; Rost F; Arenja N; Andre F; Aus dem Siepen F; Fritz T; Ehlermann P; Taeger T; Frankenstein L; Meder B; Katus HA; Buss SJ
    J Cardiovasc Magn Reson; 2016 Jun; 18(1):36. PubMed ID: 27268238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
    Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
    J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.
    Liu D; Hu K; Herrmann S; Cikes M; Ertl G; Weidemann F; Störk S; Nordbeck P
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):837-845. PubMed ID: 28265790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
    Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
    Pradel S; Magne J; Jaccard A; Fadel BM; Boulogne C; Salemi VMC; Damy T; Aboyans V; Mohty D
    Int J Cardiovasc Imaging; 2019 May; 35(5):845-854. PubMed ID: 30623354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Chimura M; Onishi T; Tsukishiro Y; Sawada T; Kiuchi K; Shimane A; Okajima K; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
    Heart; 2017 May; 103(9):679-686. PubMed ID: 27799316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
    Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients.
    Florian A; Ludwig A; Engelen M; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
    J Cardiovasc Magn Reson; 2014 Sep; 16(1):81. PubMed ID: 25315351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.